The P harmacologic and C linical E ffects of M edical C annabis

Cited by (425)

Items 101–200 of 425

1. Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation
   Francisco M. Mouro, Vânia L. Batalha, Diana G. Ferreira, Joana Esteves Coelho, Younis Baqi, Christa Elisabeth Müller, Luísa Vaqueiro Lopes, Joaquim Alexandre Ribeiro, Ana Maria Sebastião · 2017 · Neuropharmacology
2. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats
   Cristina Irimia, Ilham Y. Polis, David G. Stouffer, Loren H. Parsons · 2015 · Psychopharmacology
3. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography–Tandem Mass Spectrometry
   David M. Andrenyak, David E. Moody, Matthew H. Slawson, Daniel S. OʼLeary, Margaret Haney · 2016 · Journal of Analytical Toxicology
4. Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae
   John C. Achenbach, Jessica Hill, Joseph P. M. Hui, Michael G. Morash, Fabrice Berrué, Lee D. Ellis · 2018 · Zebrafish
5. NeuroHIV and Use of Addictive Substances
   Sulie L. Chang, Kaitlyn P. Connaghan, Yufeng Wei, Ming D. Li · 2014 · International review of neurobiology
6. Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder
   Andrea Bollom, Jasmine Austrie, William Hirsch, Judy W. Nee, Daniel Friedlander, Johanna Iturrino, Sarah Ballou, Anthony J Lembo · 2017 · Journal of Clinical Gastroenterology
7. Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
   Md Sultan Mahmud, Mohammad Sorowar Hossain, A T M Faiz Ahmed, Md Zahidul Islam, Md Emdad Sarker, Md Reajul Islam · 2021 · Molecules
8. Cannabinoids Production by Hairy Root Cultures of <i>Cannabis sativa</i> L.
   Farag, Sayed, Kayser, Oliver · 2015 · American Journal of Plant Sciences
9. Medical marijuana in neurology
   Selim R. Benbadis, Juan Sanchez‐Ramos, Ali M. Bozorg, Melissa Giarratano, Kavita Kalidas, Lara W. Katzin, Derrick S. Robertson, Tuan Vu, Amanda Smith, Theresa A. Zesiewicz · 2014 · Expert Review of Neurotherapeutics
10. Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use
    Benedikt Fischer, Sharan Kuganesan, Andréa Donatti Gallassi, Renato Malcher‐Lopes, Wim van den Brink, Evan Wood · 2015 · International Journal of Drug Policy
11. Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984–2013
    Chukwuemeka N. Okafor, Robert L. Cook, Xinguang Chen, Pamela J. Surkan, James T. Becker, STEVEN J. SHOPTAW, Eileen M Martin, Michael W Plankey · 2016 · AIDS and Behavior
12. Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity
    Francisco M. Mouro, Joaquim Alexandre Ribeiro, Ana Maria Sebastião, Neil Dawson · 2018 · Journal of Neurochemistry
13. Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
    Joshua Aviram, Gil Moshe Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmoud Abu Amna, Luiza Akria, Dmitry Goncharov et al. · 2020 · Pharmaceuticals
14. Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation–contraction coupling in mammalian skeletal muscle
    Tamás Oláh, Dóra Bodnár, Adrienn Tóth, János Vincze, János Fodor, Barbara Reischl, Adrienn Kovács, Olga Ruzsnavszky, B. Dienes, Péter Szentesi et al. · 2016 · The Journal of Physiology
15. Research grade marijuana supplied by the National Institute on Drug Abuse is genetically divergent from commercially available Cannabis
    Anna L. Schwabe, Connor J. Hansen, Richard M. Hyslop, Mitchell E. McGlaughlin · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
16. Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
    Marta Kruk-Słomka, Anna Boguszewska‐Czubara, Tomasz Słomka, Barbara Budzyńska, Grażyna Biała · 2015 · Neural Plasticity
17. Cannabis: A joint problem for patients and the dental profession
    S. Joshi, Martin P. Ashley · 2016 · BDJ
18. New vistas on cannabis use disorder
    Miriam Melis, Roberto Frau, Peter W. Kalivas, Sade M. Spencer, Vivian C. Chioma, Erica Zamberletti, Tiziana Rubino, Daniela Parolaro · 2017 · Neuropharmacology
19. New Prospect for Cancer Cachexia: Medical Cannabinoid
    Jing Wang, Yanling Wang, Mengting Tong, Hongming Pan, Da Li · 2019 · Journal of Cancer
20. Allosteric Modulators Targeting Cannabinoid cb1 and cb2 Receptors: Implications for Drug Discovery
    Francesca Gado, Serena Meini, Simone Bertini, Maria Digiacomo, Marco Macchia, Clementina Manera · 2019 · Future Medicinal Chemistry
21. Cannabis for Pain and Headaches: Primer
    Philip S. Kim, Michael Alan Fishman · 2017 · Current Pain and Headache Reports
22. Perceptions of plain packaging and health warning labels for cannabis among young adults: findings from an experimental study
    Seema Mutti-Packer, Brianne Collyer, David Carson Hodgins · 2018 · BMC Public Health
23. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
    Michelle Sexton, José M. Garcia, Aminah Jatoi, Carey S. Clark, Mark S. Wallace · 2021 · JNCI Monographs
24. Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions
    Arielle S. Gillman, Kent E. Hutchison, Angela D. Bryan · 2015 · Sports Medicine
25. Differentiating the Drug Normalization Framework: A Quantitative Assessment of Cannabis Use Patterns, Accessibility, and Acceptability Attitudes among University Undergraduates
    Kat Kolar, Patricia A. Erickson, Andrew D. Hathaway, Geraint B. Osborne · 2018 · Substance Use & Misuse
26. Attitudes to Cannabis Use and Public Prevention Information Among Young Adults: A Qualitative Interview Study With Implications for Prevention Practice
    Pia Kvillemo, Anna K. Strandberg, Johanna Gripenberg · 2022 · Frontiers in Public Health
27. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
    Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes · 2023 · Pharmaceuticals
28. Adverse pharmacokinetic interactions between illicit substances and clinical drugs
    Kodye L. Abbott, Patrick C. Flannery, Kristina S. Gill, Dawn Merton Boothe, Muralikrishnan Dhanasekaran, Sridhar Mani, Satyanarayana R. Pondugula · 2019 · Drug Metabolism Reviews
29. Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor‐independent reactive oxygen species
    Seokwoo Park, Ji‐Eun Kim, Sangmi Oh, Wonjae Cha, Jeong Hun Hah, Myung‐Whun Sung · 2014 · Head & Neck
30. Acute cannabis intoxication in the emergency department: the effect of legalization
    Baraniecki, Robert, Panchal, Puru, Malhotra, Danya Deepsee, Aliferis, Alexandra, Zia, Zaka · 2021 · BMC Emergency Medicine
31. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland
    Kathrin Zürcher, Carole Dupont, Peter Weber, Sebastian Grunt, Ilca Wilhelm, Daniela Elisabeth Eigenmann, Martina L. Reichmuth, Manfred Fankhauser, Matthias Egger, Lukas Fenner · 2021 · European Journal of Pediatrics
32. AM 841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
    Catherine M. Keenan, Martin Storr, Ganesh A. Thakur, JodiAnne T. Wood, Jim Wager‐Miller, Alex J. Straiker, Marsha Rebecca Eno, Spyros P. Nikas, Mohammad Bashashati, H Hu et al. · 2015 · British Journal of Pharmacology
33. Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
    Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda R Chumki, Zvi G. Loewy · 2016 · Parkinson s Disease
34. Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
    Denise Christina Vidot, Brenda Lerner, Raúl González · 2017 · AIDS and Behavior
35. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism
    Francisco M. Mouro, Attila Köfalvi, L. André, Younis Baqi, Christa Elisabeth Müller, Joaquim Alexandre Ribeiro, Ana Maria Sebastião · 2019 · Neuropharmacology
36. Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients
    Kuntheavy Ing Lorenzini, François R. Girardin · 2019 · Liver International
37. Teratogenic Risks from Exposure to Illicit Drugs
    Bradley D. Holbrook, William F. Rayburn · 2014 · Obstetrics and Gynecology Clinics of North America
38. Neurobiological mechanisms underlying cannabis-induced memory impairment
    Pamela Prini, Erica Zamberletti, Cristina Manenti, Marina Gabaglio, Daniela Parolaro, Tiziana Rubino · 2020 · European Neuropsychopharmacology
39. Cardiovascular Effects of Marijuana
    S. Rezkalla, Rachel V. Stankowski, R. Kloner · 2016 · Journal of Cardiovascular Pharmacology and Therapeutics
40. Cannabinoids for pediatric epilepsy? Up in smoke or real science?
    Francis M. Filloux · 2015 · PubMed Central
41. Medical marijuana in pediatric oncology: A review of the evidence and implications for practice
    Prasanna Janaki Ananth, Anne E. Reed-Weston, Joanne Wolfe · 2017 · Pediatric Blood & Cancer
42. The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance
    Jiebing Wen, Hefei Wen, J. S. Butler, Jeffery Talbert · 2021 · Health Economics
43. Current agents in development for treating behavioral and psychological symptoms associated with dementia
    Ahmed, Mehnaz, Malik, Marlene, Teselink, Johannes, Lanctôt, Krista L., Herrmann, Nathan · 2019 · Drugs & Aging
44. Medical marijuana programs — Why might they matter for public health and why should we better understand their impacts?
    Benedikt Fischer, Yoko Murphy, Paul A. Kurdyak, Elliot M. Goldner, Jürgen T. Rehm · 2015 · Preventive Medicine Reports
45. Analysis of cannabinoids in conventional and alternative biological matrices by liquid chromatography: Applications and challenges
    Athina G. Nicolaou, Marios C. Christodoulou, Ioannis J. Stavrou, Constantina P. Kapnissi‐Christodoulou · 2021 · Journal of Chromatography A
46. The effect of medical cannabis on cognitive functions: a systematic review
    Anders Wieghorst, Kirsten Kaya Roessler, Oliver Hendricks, Tonny Elmose Andersen · 2022 · Systematic Reviews
47. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain
    Ana Bagüés, Marı́a Isabel Martı́n, Eva Sánchez-Robles · 2014 · European Journal of Pharmacology
48. The endocannabinoid system in migraine: from bench to pharmacy and back
    Cristina Tassorelli, Rosaria Greco, Stephen David Silberstein · 2019 · Current Opinion in Neurology
49. Benefits, toxicity and current market of cannabidiol in edibles
    Gonzalo Astray, Juan Carlos Mejuto, Jianbo Xiao, Jesús Simal‐Gándara · 2022 · Critical Reviews in Food Science and Nutrition
50. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics
    Xinzhen Fu, Shiji Xu, Zhi Li, Kun Chen, Huaying Fan, Yu Wang, Zeping Xie, Lijuan Kou, Shumin Zhang · 2022 · AAPS PharmSciTech
51. Peripherally Restricted Cannabinoids for the Treatment of Pain
    Edgar Alfonso Romero-Sandoval, Scott Asbill, Candler A. Paige, Kiara Byrd-Glover · 2015 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
52. Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics
    Sybil Goulet-Stock, Sergio Rueda, Afshin Vafaei, Anca Ialomiteanu, Jakob Manthey, Jürgen T. Rehm, Benedikt Fischer · 2017 · European Addiction Research
53. Cannabinoids in the Management of Musculoskeletal Pain
    Kim Madden, Niek van der Hoek, Simrun Chona, Annie George, Tristiana Dalchand, Hassan Baldawi, George Mammen, Mohit Bhandari · 2018 · JBJS Reviews
54. Medical marijuana use for pediatric oncology patients: single institution experience
    Ruth Ofir, Gil Bar‐Sela, Myriam Weyl Ben‐Arush, Sergey Postovsky · 2019 · Pediatric Hematology and Oncology
55. Anesthetic considerations in medical cannabis patients
    Elyad M. Davidson, Noa Raz, Aharon M. Eyal · 2020 · Current Opinion in Anaesthesiology
56. Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
    Klaudia Berk, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Żywno, Adrian Chabowski · 2021 · Journal of Clinical Medicine
57. Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US
    Tanner D. Wakefield, Stanton A. Glantz, Dorie E. Apollonio · 2022 · JAMA Network Open
58. Marijuana Misadventures in Children
    Justin W. Heizer, Laura M. Borgelt, Ferras Bashqoy, George Sam Wang, Pamela D. Reiter · 2016 · Pediatric Emergency Care
59. Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study
    Oliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, Jette Primdahl, Ellen‐Margrethe Hauge, Torkell Ellingsen, Tina I. Horsted, Anja Godske Bachmann, Anne Gitte Loft, Anders Bo Bojesen et al. · 2019 · BMJ Open
60. Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers
    Emilio Fernández-Egea, Linda Scoriels, S. Theegala, Maria Giro, Susan Elizabeth Ozanne, Keith Burling, Peter Brian Jones · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
61. Unintentional Pediatric Marijuana Exposures at a Tertiary Care Children's Hospital in Washington State
    Anita Anne Thomas, Tavis M. K. Dickerson, Suzan S. Mazor · 2018 · Pediatric Emergency Care
62. Pharmacists and the future of cannabis medicine
    Natalie S. Schmitz, Lucas Richert · 2019 · Journal of the American Pharmacists Association
63. A pharmacological characterization of Cannabis sativa chemovar extracts
    Alykhan Devsi, Brett Kiyota, Theophile Ouellette, Andrew P. Hegle, Ricardo E. Rivera-Acevedo, Jasper Wong, Ying Dong, Michael K. Pugsley, Timothy Fung · 2020 · Journal of Cannabis Research
64. Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids
    Omar M. E. Abdel‐Salam · 2016 · Asian Pacific Journal of Tropical Medicine
65. Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
    Siyuan Shen, Chao Wu, Zhiqian Yang, Kexin Wang, Zhenhua Shao, Wei Yan · 2025 · Acta Pharmacologica Sinica
66. Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
    Francesca Gado, Kawthar A. Mohamed, Serena Meini, Rebecca Ferrisi, Simone Bertini, Maria Digiacomo, Felicia D’Andrea, Lesley Stevenson, Robert B. Laprairie, Roger G. Pertwee et al. · 2020 · European Journal of Medicinal Chemistry
67. The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
    Clara Andradas, Alexandra Truong, Jacob Byrne, Raelene Endersby · 2021 · Cancers
68. Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement
    Bradford P. Whitcomb, Christopher V. Lutman, Michael L. Pearl, Erin E. Medlin, Emily N. Prendergast, Katina M. Robison, William M. Burke · 2020 · Gynecologic Oncology
69. Cannabidiol Discovery and Synthesis—a Target‐Oriented Analysis in Drug Production Processes
    Anderson R. Aguillón, Raquel A. C. Leão, Leandro S. M. Miranda, Rodrigo O. M. A. de Souza · 2020 · Chemistry - A European Journal
70. Cannabidiol for the Treatment of Drug-Resistant Epilepsy in Children: Current State of Research
    Victoria Evans, Thomas B. DeMarse, Marcelo Febo, Cynthia R. Johnson, Paul Richard Carney, Christopher L. Anderson · 2017 · Journal of Pediatric Neurology
71. Endocannabinoids in the treatment of gastrointestinal inflammation and symptoms
    Marcella Pesce, Giuseppe Esposito, Giovanni Sarnelli · 2018 · Current Opinion in Pharmacology
72. Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?
    Donald E. Greydanus, Gabriel Kaplan, Louis E. Baxter, Dilip R. Patel, Cynthia L. Feucht · 2015 · Disease-a-Month
73. Comprehensive Ethnopharmacological Analysis of Medicinal Plants in the UAE: Lawsonia inermis, Nigella sativa, Ziziphus spina-christi, Allium cepa, Allium sativum, Cymbopogon schoenanthus, Matricaria aurea, Phoenix dactylifera, Portulaca oleracea, Reichardia tingitana, Salvadora persica, Solanum lycopersicum, Trigonella foenum-graecum, Withania somnifera, and Ziziphus lotus
    Razan Almasri, Alaa S. Bedir, Seham M. Al Raish · 2025 · Nutrients
74. Recent legalization of cannabis use: effects on sleep, health, and workplace safety
    Nicole P. Bowles, Maya Xolal Herzig, Steven A. Shea · 2017 · Nature and Science of Sleep
75. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis
    Joshua Aviram, Gil Moshe Lewitus, Dorit Pud, Shiri Procaccia, Paula Berman, Ben Yellin, Yelena Vysotski, Or Hazan, Elon Eisenberg, David Meiri · 2021 · Pharmacological Research
76. Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies
    Sara Pisani, Katie McGoohan, Latha Velayudhan, Sagnik Bhattacharyya · 2021 · Drugs & Aging
77. Cannabinoids in the Treatment of Back Pain
    Teddy E. Kim, Robert Kyle Townsend, Charles L. Branch, Edgar Alfonso Romero-Sandoval, Wesley Hsu · 2020 · Neurosurgery
78. A Rapid Nano-Liquid Chromatographic Method for the Analysis of Cannabinoids in Cannabis sativa L. Extracts
    Lucie Žampachová, Zeineb Aturki, Francesca Mariani, Petr Bednář · 2021 · Molecules
79. Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis
    Brienna N. Meffert, Danielle M. Morabito, Michelle K. Mosich, Mallory Loflin, James E. Sottile, Adrienne J. Heinz · 2018 · Current Drug Research Reviews
80. The endocannabinoid system: Novel targets for treating cancer induced bone pain
    Jia Sun, Ya‐Qun Zhou, Shuping Chen, Xiaomei Wang, Bingyang Xu, Danyang Li, Yuke Tian, Dawei Ye · 2019 · Biomedicine & Pharmacotherapy
81. Effects of topical treatment of cannabidiol extract in a unique manuka factor 5 manuka honey carrier on second intention wound healing on equine distal limb wounds: a preliminary study
    VC McIver, AS Tsang, NE Symonds, Nigel R. Perkins, E Uquillas, CM Dart, Leo B. Jeffcott, AJ DART · 2020 · Australian Veterinary Journal
82. Comparative Genetic Structure of Cannabis sativa Including Federally Produced, Wild Collected, and Cultivated Samples
    Anna L. Schwabe, Connor J. Hansen, Richard M. Hyslop, Mitchell E. McGlaughlin · 2021 · Frontiers in Plant Science
83. Medical Cannabis: A Review from the American Society of Pain and Neuroscience
    Natalie H. Strand, Ryan Steven D'Souza, Jay V. Karri, Hemant Kalia, Jacqueline S. Weisbein, Brian J Kassa, Nasir Hussain, Ahish Chitneni, Ryan R. Budwany, Jonathan Michael Hagedorn et al. · 2023 · Journal of Pain Research
84. CNR1 variation is associated with the age at onset in Huntington disease
    Eugen Kloster, Carsten Saft C, Jörg T. Epplen, Larissa Arning · 2013 · European Journal of Medical Genetics
85. Cannabis Involvement and Nonsuicidal Self-Injury: A Discordant Twin Approach
    Lauren R. Few, Julia D. Grant, Elliot C. Nelson, Timothy J. Trull, Richard A. Grucza, Kathleen Keenan Bucholz, Karin J. H. Verweij, Nicholas G. Martin, Dixie J. Statham, Pamela A. F. Madden et al. · 2016 · Journal of Studies on Alcohol and Drugs
86. Potential regional air quality impacts of cannabis cultivation facilities in Denver, Colorado
    Chi‐Tsan Wang, Christine Wiedinmyer, Kirsti Ashworth, P. C. Harley, John Ortega, Quazi Z. Rasool, William Vizuete · 2019 · Atmospheric chemistry and physics
87. Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study
    Ilana Monica Braun, Fremonta L. Meyer, Joshua J. Gagne, Lida Nabati, David P. Yuppa, M.A. Carmona, Harold J. Burstein, Joji Suzuki, Manan M. Nayak, Yolanda Martins · 2017 · Psycho-Oncology
88. Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action
    Juwairiah Remali, Wan Mohd Aizat · 2024 · Heliyon
89. Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Marta Vázquez, Carlos García‐Carnelli, Cecilia Maldonado, Pietro L. Fagiolino · 2021 · Advances in experimental medicine and biology
90. Characteristics of Individuals with Spinal Cord Injury Who Use Cannabis for Therapeutic Purposes
    Claudia Drossel, Martin B. Forchheimer, Michelle A. Meade · 2016 · Topics in Spinal Cord Injury Rehabilitation
91. Cannabis resin in the region of Madrid: Adulteration and contamination
    Manuel Pérez Moreno, Pilar Pérez‐Lloret, Juncal González‐Soriano, Inmaculada Santos-Álvarez · 2019 · Forensic Science International
92. Source of cannabinoids: what is available, what is used, and where does it come from?
    Nicola Specchio, Nicola Pietrafusa, Judith Helen Cross · 2020 · Epileptic Disorders
93. Process Intensification for Obtaining a Cannabidiol Intermediate by Photo-oxygenation of Limonene under Continuous-Flow Conditions
    Anderson R. Aguillón, Raquel A. C. Leão, Kleber Thiago de Oliveira, Timothy J. Brocksom, Leandro S. M. Miranda, Rodrigo O. M. A. de Souza · 2020 · Organic Process Research & Development
94. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen, Gil Bar‐Sela · 2021 · Current Treatment Options in Oncology
95. Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review
    Judy Trac, Jacob M. Keck, Joseph E. Deweese · 2021 · Journal of Cannabis Research
96. Psilocybin Outside the Clinic
    Kent E. Hutchison, Jake F. Hooper, Hollis C. Karoly · 2025 · JAMA Psychiatry
97. Postoperative Pain Management in Pediatric Patients Undergoing Cardiac Surgery: Where Are We Heading?
    Uri Pollak, Ronald A. Bronicki, Barbara-Jo Achuff, Paul A. Checchia · 2019 · Journal of Intensive Care Medicine
98. Pain Management and Work Capacity: Evidence From Workers’ Compensation and Marijuana Legalization
    Rahi Abouk, Keshar Ghimire, Johanna Catherine Maclean, David Powell · 2023 · Journal of Policy Analysis and Management
99. Cannabis: una ilusión cognitiva
    Gonzalo Galván, Manuel Guerrero-Martelo, Francisco Vásquez De la Hoz · 2016 · Revista Colombiana de Psiquiatría
100. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders
     Susanne W. Duvall, Olivia Jasmine Lindly, Katharine E. Zuckerman, Michael E. Msall, Melissa Weddle · 2019 · PEDIATRICS